Circadian Variations of Prostaglandin in Sleep Apnea

NCT01096433 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2012-01-26

No results posted yet for this study

Summary

The purpose of this study is to evaluate the associations of circadian variations, sleep architecture, hypertension and prostanoids in the patients with sleep apnea. In addition, the patients introduced to continuous positive airway pressure(CPAP) treatment, the effects of CPAP are also evaluated.

Conditions

  • Sleep Apnea
  • Continuous Positive Airway Pressure
  • Prostaglandins
  • Circadian Variations

Interventions

DEVICE

CPAP treatment

maintains upper airway patency and minimizes the obstructive events

Sponsors & Collaborators

  • Kyoto University

    lead OTHER

Principal Investigators

  • Kazuo Chin, MD,PhD · Kyoto University, Graduate School of Medicine

  • Yuichi Chihara, MD · Kyoto University Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2011-10-31
Completion
2012-01-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01096433 on ClinicalTrials.gov